Sign in
CompletedPhase 3

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Key facts

Who runs it
ModernaTX, Inc.
Where
Albany, Albuquerque, Alexandria, Anderson, Annapolis, Anniston, Asheville, Athens, Atlantis, Augusta, Austin, Baton Rouge, Beaumont, Binghamton, Birmingham, Blackfoot, Brookline, Brooklyn, Brownsville, Buffalo, Charleston, Charlotte, Chattanooga, Chesterfield, Chicago, Cincinnati, Colton, Columbia, Columbus, Corvallis, Covina, Crystal River, Cullman, Dayton, Decatur, East Syracuse, Edmond, El Paso, Fort Collins, Fort Worth, Gaffney, Gaithersburg, Glendale, Grand Island, Gulfport, Hampton, Hartsdale, Henderson, Hialeah, Hollywood, Honolulu, Houston, Huntington Park, Huntsville, Inverness, Jackson, Jacksonville, Jersey City, Johnson City, Jupiter, Keller, La Mesa, Lafayette, Lake City, Lake Mary, Las Vegas, Leesburg, Lenexa, Lincoln, Little Rock, Long Beach, Longmont, Los Angeles, Maitland, Melrose Park, Meridian, Miami, Miami Lakes, Missoula, Mobile, Monroe, Morehead City, Myrtle Beach, New Orleans, New York, Newport Beach, Newport News, Norfolk, North Hollywood, Northridge, Omaha, Orlando, Overland Park, Pembroke Pines, Philadelphia, Phoenix, Plano, Port Saint Lucie, Portland, Portsmouth, Prairieville, Prosper, Providence, Raleigh, Rapid City, Redding, Richmond, Riverside, Rochester, Rockville, Rogers, Rolling Hills Estates, Salisbury, Salt Lake City, San Antonio, San Bernardino, San Diego, San Marcos, Santa Ana, Savannah, Sioux City, South Jordan, Southfield, Spartanburg, Spokane, Springfield, St Louis, St. Petersburg, Stamford, Stephenville, Stockbridge, Sugar Land, Tampa, Tempe, Tomball, Town and Country, Tucson, Tulsa, Union, Uniontown, Valparaiso, Vestal, Walnut Creek, Warren Township, Waterbury, Wenatchee, Wichita, Wilmington, Winchester, Winston-Salem, Winter Park, and Yukon, United StatesSee the 188 sitesAlso in 10 other countries, 119 sites
Status
Completed
Phase
Phase 3
People taking part
40,805 people enrolled
Started
16 Sept 2024
Ended
21 Aug 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • mRNA-1010
  • Fluarix®
  • Influsplit® Tetra
  • Fluarix Tetra
  • Alpharix® Tetra
Record updated
16 September 2026

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Capable of giving signed informed consent, which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in the protocol
  • Participants who are assigned female at birth or can become pregnant are eligible to participate if:; The participant is a person of nonchildbearing potential (PONCBP) or; The participant is a person of childbearing potential (POCBP) who:
  • Is not breast/chest feeding
  • Is using an acceptable contraceptive method at least 28 days prior to Day 1 (Baseline) to at least 90 days after Day 1 (Baseline)
  • Has a negative highly sensitive pregnancy test (urine or serum as required by local regulation or institutional review board [IRB]/independent ethics committee [IEC]) at the Screening Visit and before study intervention (if the Day 1 [Baseline] Visit is not on the same day as the Screening Visit)

Who cannot take part

  • Acutely ill or febrile (temperature ≥38.0 degrees Celsius (℃) [100.4° Fahrenheit [F]]) within 72 hours prior to Day 1 (Baseline)
  • Tested positive for influenza by local health authority-approved testing methods within 180 days prior to Day 1 (Baseline)
  • Malignancy within 2 years prior to Day 1 (Baseline) (adequately treated basal cell carcinoma and squamous cell carcinoma are allowed)
  • Received corticosteroids at ≥10 milligram (mg)/day of prednisone or equivalent for >14 days in total within 90 days prior to Day 1 (Baseline) or is anticipating the need for corticosteroids at any time during the study
  • Received systemic immunosuppressive treatment, including long-acting biological therapies that affect immune responses (for example, infliximab), within 180 days prior to Day 1 (Baseline) or plans to do so during the study
  • Treated with antiviral therapies for influenza (for example, Tamiflu) within 180 days prior to Day 1 (Baseline)
  • Received any vaccine authorized or approved by local health agency within 28 days prior to Day 1 (Baseline) or plans to do so within 14 days after Day 1 (Baseline)
  • Received a licensed seasonal influenza vaccine within 180 days prior to Day 1 (Baseline) or plans to do so (outside of this study) at any time during the study
  • Received an investigational seasonal influenza vaccine within 1 year prior to Day 1 (Baseline). Note: participants from mRNA-1010-P304 Season 1 are NOT eligible to re enroll into Season 2
  • Participated in a clinical study with investigational treatment within 90 days prior to Day 1 (Baseline) based on the medical history interview or plans to do so while participating in this study
  • History of a diagnosis or condition that, in the judgment of the Investigator, is clinically unstable or may affect participant safety, assessment of study endpoints, assessment of immune response, or adherence to study procedures
  • Reported history of congenital or acquired immunodeficiency, immunosuppressive condition, asplenia, or recurrent severe infections disease
  • History of anaphylaxis or severe hypersensitivity reaction requiring medical intervention after receipt of any of the following: mRNA vaccine or therapeutic; components of an mRNA vaccine or therapeutic; influenza vaccine; or components of an influenza vaccine, including egg protein
  • Close contact with someone with laboratory-confirmed influenza infection or with someone who has been treated with antiviral therapies for influenza (for example, Tamiflu®/oseltamivir) within 5 days prior to Day 1 (Baseline)
  • Is working or has worked as study personnel or is an immediate family member or house member of study personnel, study staff, or Sponsor personnel

Where in United States

Also in 10 other countries, 119 sites

  • JAVARAAlbany, United States
  • AXCES Research Group - Sante FeAlbuquerque, United States
  • DM Clinical Research-AlbuquerqueAlbuquerque, United States
  • JavaraAlexandria, United States
  • Velocity Clinical Research, AndersonAnderson, United States
  • Privia Medical GroupAnnapolis, United States
  • Pinnacle Research Group, LLCAnniston, United States
  • Asheville Clinical ResearchAsheville, United States
  • North Alabama Research Center LLCAthens, United States
  • JEM Research InstitueAtlantis, United States
  • Alliance for Multispecialty ResearchAugusta, United States
  • Avant Reseach AssociatesAustin, United States
  • Tekton Research, IncAustin, United States
  • Velocity Clinical Research - Baton RougeBaton Rouge, United States
  • Tekton Research, LLCBeaumont, United States
  • Velocity Clinical Research - BinghamtonBinghamton, United States
  • EmVenio Research Brimingham, ALBirmingham, United States
  • Flourish ResearchBirmingham, United States
  • Bingham Memorial HospitalBlackfoot, United States
  • DM Clinical Research - BrooklineBrookline, United States
  • DM ClinicalBrooklyn, United States
  • Headlands Research - BrownsvilleBrownsville, United States
  • RCR - BuffaloBuffalo, United States
  • Charleston Clinical Trials, LLCCharleston, United States
  • DelRicht ResearchCharleston, United States
  • DelRicht Research, LLCCharlotte, United States
  • M3 Wake Research/ClinSearch, LLCChattanooga, United States
  • Clinical Research ProfessionalsChesterfield, United States
  • EmVenio ResearchChicago, United States
  • Great Lakes Clinical TrialsChicago, United States
  • Community ResearchCincinnati, United States
  • Velocity Clinical Research - CincinnatiCincinnati, United States
  • Velocity Clinical Research, Mt. AuburnCincinnati, United States
  • Benchmark Research - ColtonColton, United States
  • Velocity Clinical Research, SpartanburgColumbia, United States
  • Centricity Research ColumbusColumbus, United States
  • IACT HealthColumbus, United States
  • The Corvallis ClinicCorvallis, United States
  • Flourish ResearchCovina, United States
  • Nature Coast Clinical Research, LLC - Crystal RiverCrystal River, United States
  • Cullman Clinical TrialsCullman, United States
  • Midwest Clinical Research CenterDayton, United States
  • CenExel iResearch, LLCDecatur, United States
  • Velocity Clinical Research, SyracuseEast Syracuse, United States
  • Tekton Research, Inc - EdmondEdmond, United States
  • 3A Research, LLCEl Paso, United States
  • Tekton Research - Fort CollinsFort Collins, United States
  • Benchmark ResearchFort Worth, United States
  • HeliosFort Worth, United States
  • Velocity Clinical Research, GaffneyGaffney, United States
  • Cenexel CBH (CBH Health)Gaithersburg, United States
  • Lenzmeier Family MedicineGlendale, United States
  • Velocity Clinical Research - Grand IslandGrand Island, United States
  • DelRicht Research at Gulfport MemorialGulfport, United States
  • Velocity Clinical Research, HamptonHampton, United States
  • IMA Clinical ResearchHartsdale, United States
  • Henderson Clinical TrialsHenderson, United States
  • Homestead Associates in Research,IncHialeah, United States
  • CenExel RCAHollywood, United States
  • East-West Medical Research InstituteHonolulu, United States
  • DM Clinical Research - BellaireHouston, United States
  • DM Clinical Research- CyfairHouston, United States
  • Helios Clinical ResearchHouston, United States
  • Velocity Clinical Research-Huntington ParkHuntington Park, United States
  • Optimal ResearchHuntsville, United States
  • Nature Coast Clinical Research, LLC - InvernessInverness, United States
  • Helios Clinical ResearchJackson, United States
  • Jacksonville Center for Clinical ResearchJacksonville, United States
  • Westside Center for Clinical ResearchJacksonville, United States
  • DM Clinical Research - New JerseyJersey City, United States
  • MultiSpeciality Clinical ResearchJohnson City, United States
  • Health Awareness, IncJupiter, United States
  • Helios CR, Inc. Keller TxKeller, United States
  • Velocity Clinical Research, San DiegoLa Mesa, United States
  • Velocity Clinical Research, LafayetteLafayette, United States
  • M3 Wake Research/MSRA, LLCLake City, United States
  • Accel Clinical ResearchLake Mary, United States
  • M3 Wake Research/CRCN, LLCLas Vegas, United States
  • Office of Michael B. Jacobs, MDLas Vegas, United States
  • Clinical Site Partners LeesburgLeesburg, United States
  • Johnson County Clin-Trials (JCCT)Lenexa, United States
  • Platinum Research Network, LLCLincoln, United States
  • Baptist Health Center for Clinical ResearchLittle Rock, United States
  • Long Beach Research Institute, LLCLong Beach, United States
  • Tekton Research, Inc - Longmont CenterLongmont, United States
  • Velocity Clinical Research, WestlakeLos Angeles, United States
  • ARS - Meridien ResearchMaitland, United States
  • K2 Medical ResearchMaitland, United States
  • DM Clinical Research- River ForestMelrose Park, United States
  • Velocity Clinical Research, BoiseMeridian, United States
  • Miami Clinical ResearchMiami, United States
  • South Florida Research Center, Inc.Miami, United States
  • Suncoast Research Associates, LLCMiami, United States
  • Floridian Clinical ResearchMiami Lakes, United States
  • Boeson Research MSOMissoula, United States
  • Elias Research AssociatesMissoula, United States
  • Velocity Clinical ResearchMobile, United States
  • IMA Clinical Research MonroeMonroe, United States
  • Lucas ResearchMorehead City, United States
  • Carolina Health SpecialistsMyrtle Beach, United States
  • Delricht ResearchNew Orleans, United States
  • Velocity Clinical ResearchNew Orleans, United States
  • IMA ResearchNew York, United States
  • M3 Wake Research/PRI, LLCNewport Beach, United States
  • Health Research of Hampton Roads, Inc.Newport News, United States
  • Velocity Clinical Research - NorfolkNorfolk, United States
  • Carbon Health North HollywoodNorth Hollywood, United States
  • Valley Clinical Trials, Inc.Northridge, United States
  • Velocity Clinical Research - OmahaOmaha, United States
  • Headlands ResearchOrlando, United States
  • DelRicht Research - Overland ParkOverland Park, United States
  • Suncoast Research AssociatesPembroke Pines, United States
  • DM Clinical Research - PhiladelphiaPhiladelphia, United States
  • DM Clinical ResearchPhoenix, United States
  • Helios Clinical ResearchPhoenix, United States
  • Research Your HealthPlano, United States
  • Health Awareness INCPort Saint Lucie, United States
  • Summit ResearchPortland, United States
  • Velocity Clinical Research-PortsmouthPortsmouth, United States
  • DelRicht Research @ Neighborhood HealthPrairieville, United States
  • DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINEProsper, United States
  • Velocity Clinical Research, ProvidenceProvidence, United States
  • Eximia Clinical ResearchRaleigh, United States
  • M3 Wake Research, Inc.Raleigh, United States
  • Black Hills Center for American Indian HealthRapid City, United States
  • Paradigm ResearchRedding, United States
  • Clinical Research Partners, LLCRichmond, United States
  • Artemis Institute for Clinical ResearchRiverside, United States
  • Rochester Clinical Research, IncRochester, United States
  • Matthew Mintz ClinicRockville, United States
  • Velocity Clinical Research - CovingtonRockville, United States
  • Woodland ResearchRogers, United States
  • Peninsula Research Associates PraRolling Hills Estates, United States
  • Accellacare US Inc.Salisbury, United States
  • CenExel - JBRSalt Lake City, United States
  • J. Lewis Research, Inc. / Foothill Family ClinicSalt Lake City, United States
  • J.Lewis Research IncSalt Lake City, United States
  • Synexus Clinical Research US, Inc.Salt Lake City, United States
  • DM Clinical ResearchSan Antonio, United States
  • IMA Clinical ResearchSan Antonio, United States
  • Tekton Research Inc - San AntonioSan Antonio, United States
  • Velocity Clinical Research- BanningSan Bernardino, United States
  • Artemis Institute for Clinical Research - Research SiteSan Diego, United States
  • WHCR- M3 Wake ResearchSan Diego, United States
  • Wr-McCr, LlcSan Diego, United States
  • San Marcos Family MedicineSan Marcos, United States
  • Velocity Clinical ResearchSanta Ana, United States
  • Cenexel Iresearch - SavannahSavannah, United States
  • Javara-Privia Medical Group, Georgia LLCSavannah, United States
  • Velocity Clinical Research - SavannahSavannah, United States
  • Velocity Clinical Research - Sioux CitySioux City, United States
  • J. Lewis Research, Inc/Jordan River Family MedicineSouth Jordan, United States
  • DM Clinical ResearchSouthfield, United States
  • Great Lakes Research InstituteSouthfield, United States
  • Headlands Research - DetroitSouthfield, United States
  • Spartanburg Medical ResearchSpartanburg, United States
  • Velocity Clinical Research SpokaneSpokane, United States
  • ClinvestSpringfield, United States
  • DelRicht ResearchSpringfield, United States
  • Sundance Clinical Research, LLCSt Louis, United States
  • IMA Clinical Research WarrenSt. Petersburg, United States
  • Stamford Therapeutics ConsortiumStamford, United States
  • Stephenville Medical & Surgical Clinic, PAStephenville, United States
  • Clinical Research Atlanta - HeadlandsStockbridge, United States
  • Breco Research - A Tarheel Clinical Research SiteSugar Land, United States
  • DM Clinical Research - SugarlandSugar Land, United States
  • Forward Clinical Trials - DermatologyTampa, United States
  • Fiel Family and Sports MedicineTempe, United States
  • DM Clinical ResearchTomball, United States
  • DM Clinical Research, TomballTomball, United States
  • DelrichtTown and Country, United States
  • Arizona Liver HealthTucson, United States
  • Delricht TateTulsa, United States
  • Velocity Clinical Research UnionUnion, United States
  • Preferred Primary Care PhysiciansUniontown, United States
  • Velocity Clinical Research, ValparaisoValparaiso, United States
  • Velocity Clinical Research - VestalVestal, United States
  • Diablo Clinical ResearchWalnut Creek, United States
  • IMA Clinical Research WarrenWarren Township, United States
  • Chase Medical Research, LLCWaterbury, United States
  • Confluence HealthWenatchee, United States
  • AMRWichita, United States
  • Accellacare Research WilmingtonWilmington, United States
  • Trial Management Associates, LLCWilmington, United States
  • Amherst Family PracticeWinchester, United States
  • Javara - Wake Forest University Health SciencesWinston-Salem, United States
  • Clinical Site Partners, LLCWinter Park, United States
  • Tekton Research, Inc - Yukon LocationYukon, United States

About the trial

What the trial wants to find out

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1010, and to evaluate relative vaccine efficacy (rVE) of mRNA-1010 versus an active comparator against reverse transcription polymerase chain reaction (RT-PCR)-confirmed protocol-defined influenza-like illness (ILI) caused by any influenza A or B strains.

The 2 groups in the trial

  • mRNA-1010Treatment being tested

    Participants will receive a single injection of mRNA-1010 on Day 1.

  • Fluarix®, Fluarix Tetra, Influsplit® Tetra, Alpharix® TetraExisting treatment, for comparison

    Participants will receive a single injection of active comparator trivalent influenza vaccine (TIV) or quadrivalent influenza vaccine (QIV) (Fluarix®, Fluarix Tetra, Influsplit® Tetra, Alpharix® Tetra) on Day 1.

    Treatment: Fluarix®, Influsplit® Tetra, Fluarix Tetra, and Alpharix® Tetra

Data and sources

Registry record
Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
A Phase 3, Randomized, Observer-blind, Active-controlled, Case-driven Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Seasonal Influenza Vaccine Compared With a Licensed Inactivated Seasonal Influenza Vaccine in Adults ≥50 Years of Age
Publications
Record updated
16 September 2026